| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Du Toit Loots | |
| Martijn van der Kuip | |||
| Shayne Mason | |||
| A Marceline Tutu Van Furth | |||
| Regan Solomons | |||
| Simon Isaiah | |||
| P2860 | cites work | The human urine metabolome | Q21132532 |
| Utility of a novel lipoarabinomannan assay for the diagnosis of tuberculous meningitis in a resource-poor high-HIV prevalence setting | Q21231998 | ||
| Interferon- release assays for the diagnosis of active tuberculosis: a systematic review and meta-analysis | Q22241772 | ||
| Interleukin 6 induces the expression of vascular endothelial growth factor | Q24316308 | ||
| Direct oxidation of glucose-6-phosphate, 6-phosphogluconate and pentose-5-phosphates by enzymes of animal origin | Q24531277 | ||
| Microbiota and Neurological Disorders: A Gut Feeling | Q24570085 | ||
| Microglia and neuroinflammation: a pathological perspective | Q24799838 | ||
| Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection. | Q24812332 | ||
| Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. | Q46414083 | ||
| Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism | Q46565524 | ||
| LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease. | Q46831696 | ||
| Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils | Q46943421 | ||
| Gut Microbiota Dysfunction as Reliable Non-invasive Early Diagnostic Biomarkers in the Pathophysiology of Parkinson's Disease: A Critical Review | Q47111758 | ||
| The role of microbial amyloid in neurodegeneration. | Q47265139 | ||
| Comparison of Interferon-γ Release Assays and the Tuberculin Skin Test for Diagnosis of Tuberculosis in Human Immunodeficiency Virus: A Systematic Review | Q47284740 | ||
| Host-microbe interaction in the gastrointestinal tract. | Q47691807 | ||
| Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia | Q47696803 | ||
| Gut Microbiota and the Neuroendocrine System | Q47832545 | ||
| Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid | Q47969608 | ||
| Vascular endothelial growth factor as a marker of disease activity in neurotuberculosis | Q48009226 | ||
| Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain | Q48183019 | ||
| Oxidative stress in bacterial meningitis | Q48283291 | ||
| Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis | Q48373540 | ||
| VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability | Q48387418 | ||
| Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone. | Q48439130 | ||
| Twenty years of pediatric tuberculous meningitis: a retrospective cohort study in the western cape of South Africa. | Q48660616 | ||
| Expression of vascular endothelial growth factor in tuberculous meningitis. | Q48840753 | ||
| Antibody neutralization of vascular endothelial growth factor (VEGF) fails to attenuate vascular permeability and brain edema in experimental pneumococcal meningitis. | Q49049522 | ||
| The Gut Microbiome and Multiple Sclerosis. | Q50133998 | ||
| Urinary p-cresol is elevated in young French children with autism spectrum disorder: a replication study. | Q50305926 | ||
| Urinary p-cresol is elevated in small children with severe autism spectrum disorder. | Q50312706 | ||
| Erythropoietin prevents cognitive impairment and oxidative parameters in Wistar rats subjected to pneumococcal meningitis. | Q50355940 | ||
| Diagnostic and prognostic value of Mycobacterium tuberculosis complex specific interferon gamma release assay in patients with tuberculous meningitis | Q83765634 | ||
| Diagnosis and classification of diabetes mellitus | Q85777959 | ||
| Urine reflection of changes in blood | Q85890637 | ||
| Protein Oxidation Biomarkers and Myeloperoxidase Activation in Cerebrospinal Fluid in Childhood Bacterial Meningitis | Q90460245 | ||
| The Gut-Brain Axis in Neurodegenerative Diseases and Relevance of the Canine Model: A Review | Q91637522 | ||
| You are what you eat: diet, health and the gut microbiota | Q91827145 | ||
| The altered human serum metabolome induced by a marathon | Q92105319 | ||
| The GC-MS metabolomics signature in patients with fibromyalgia syndrome directs to dysbiosis as an aspect contributing factor of FMS pathophysiology | Q92663512 | ||
| Tuberculous meningitis in children is characterized by compartmentalized immune responses and neural excitotoxicity | Q92757163 | ||
| Brain abscess in immunocompetent adult patients | Q92853364 | ||
| The Microbiota-Gut-Brain Axis | Q92952672 | ||
| Gut Microbiota Profiling: Metabolomics Based Approach to Unravel Compounds Affecting Human Health | Q26738283 | ||
| Urinary Biomarkers of Brain Diseases | Q26769944 | ||
| Breaking down the barriers: the gut microbiome, intestinal permeability and stress-related psychiatric disorders | Q26777279 | ||
| Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases | Q26782677 | ||
| Brain-gut-microbiota axis in Parkinson's disease | Q26784403 | ||
| Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease | Q26849232 | ||
| Pathogens penetrating the central nervous system: infection pathways and the cellular and molecular mechanisms of invasion | Q27027234 | ||
| Interactions between the microbiota and the immune system | Q27028155 | ||
| Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo | Q27860578 | ||
| A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives | Q28068709 | ||
| Host-pathogen interactions in bacterial meningitis | Q28077430 | ||
| Standardizing the experimental conditions for using urine in NMR-based metabolomic studies with a particular focus on diagnostic studies: a review | Q28083342 | ||
| Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 | ||
| Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited | Q28240828 | ||
| Gut microbes and the brain: paradigm shift in neuroscience | Q28251501 | ||
| The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces | Q28263907 | ||
| Myeloperoxidase exerts microbicidal activity against Mycobacterium tuberculosis | Q28343452 | ||
| ¹³C metabolic flux analysis identifies an unusual route for pyruvate dissimilation in mycobacteria which requires isocitrate lyase and carbon dioxide fixation | Q28479236 | ||
| Functional characterization of a vitamin B12-dependent methylmalonyl pathway in Mycobacterium tuberculosis: implications for propionate metabolism during growth on fatty acids | Q28487127 | ||
| Role of the methylcitrate cycle in Mycobacterium tuberculosis metabolism, intracellular growth, and virulence | Q28487215 | ||
| Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis | Q28539365 | ||
| Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis | Q28568567 | ||
| Gut to brain interaction in Autism Spectrum Disorders: a randomized controlled trial on the role of probiotics on clinical, biochemical and neurophysiological parameters | Q28829153 | ||
| From the microbiome to the central nervous system, an update on the epidemiology and pathogenesis of bacterial meningitis in childhood | Q29248091 | ||
| An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system | Q29614267 | ||
| Vascular-specific growth factors and blood vessel formation | Q29614780 | ||
| Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin | Q29615449 | ||
| Structure and function of the blood-brain barrier | Q29615699 | ||
| Biological roles of oligosaccharides: all of the theories are correct | Q29616459 | ||
| Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour | Q29617115 | ||
| The impact of the gut microbiota on human health: an integrative view | Q29617446 | ||
| Myeloperoxidase: friend and foe | Q29619070 | ||
| Microglia: a sensor for pathological events in the CNS | Q29620556 | ||
| Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni | Q30437068 | ||
| Preliminary clinical evaluation of meningococcal disease and bacterial meningitis by ultrasonic enhancement | Q30494995 | ||
| Brain-gut axis in health and disease | Q32100234 | ||
| Clinical features and prognostic factors in adults with bacterial meningitis | Q33363468 | ||
| Accuracy of the interferon-γ release assay for the diagnosis of active tuberculosis among HIV-seropositive individuals: a systematic review and meta-analysis | Q36083810 | ||
| Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis. | Q36171566 | ||
| The mucosal immune system: master regulator of bidirectional gut-brain communications | Q36252032 | ||
| Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue | Q36363302 | ||
| Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system | Q36363532 | ||
| Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin | Q36366651 | ||
| An update on bacterial brain abscess in immunocompetent patients | Q36371189 | ||
| Immunoglobulin A1 protease, an exoenzyme of pathogenic Neisseriae, is a potent inducer of proinflammatory cytokines. | Q36375414 | ||
| Identification and validation of urinary metabolite biomarkers for major depressive disorder | Q36508139 | ||
| Improved diagnostic sensitivity for tuberculous meningitis with Xpert(®) MTB/RIF of centrifuged CSF. | Q36622358 | ||
| Oxidative stress in pneumococcal meningitis: a future target for adjunctive therapy? | Q36704087 | ||
| Bacteria and viruses induce production of interferon in the cerebrospinal fluid of children with acute meningitis: a study of 57 cases and review | Q36711005 | ||
| Vascular permeability factor: A unique regulator of blood vessel function | Q36958542 | ||
| The causative pathogen determines the inflammatory profile in cerebrospinal fluid and outcome in patients with bacterial meningitis | Q36995799 | ||
| Caudo-rostral brain spreading of α-synuclein through vagal connections | Q37040842 | ||
| 13C-flux spectral analysis of host-pathogen metabolism reveals a mixed diet for intracellular Mycobacterium tuberculosis | Q37119991 | ||
| Central nervous system tuberculosis: pathogenesis and clinical aspects | Q37133651 | ||
| Insulin resistance and dysregulation of tryptophan-kynurenine and kynurenine-nicotinamide adenine dinucleotide metabolic pathways | Q37188890 | ||
| Overreactive brain responses to sensory stimuli in youth with autism spectrum disorders | Q37288248 | ||
| Perivascular spaces and the two steps to neuroinflammation | Q37329042 | ||
| Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism | Q37349845 | ||
| 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima | Q37366288 | ||
| Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia | Q37441879 | ||
| The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease | Q37490320 | ||
| Mood and gut feelings | Q37501300 | ||
| Pathogen translocation across the blood-brain barrier | Q37592281 | ||
| Lactate Shuttles in Neuroenergetics-Homeostasis, Allostasis and Beyond. | Q37620008 | ||
| Interferon-Gamma Release Assay Performance of Cerebrospinal Fluid and Peripheral Blood in Tuberculous Meningitis in China. | Q37681568 | ||
| New understandings on the pathophysiology of bacterial meningitis | Q37705951 | ||
| Matrix metalloproteinase inhibition lowers mortality and brain injury in experimental pneumococcal meningitis | Q37713247 | ||
| Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. | Q37733240 | ||
| Tuberculous meningitis: a uniform case definition for use in clinical research | Q37786102 | ||
| Maternal separation as a model of brain-gut axis dysfunction | Q37795656 | ||
| Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis | Q37804607 | ||
| Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. | Q50501492 | ||
| Increased blood-brain barrier permeability and endothelial abnormalities induced by vascular endothelial growth factor. | Q51978147 | ||
| Calcium, free radicals and excitotoxins in neuronal apoptosis. | Q52530808 | ||
| Intrathecal production and secretion of vascular endothelial growth factor during Cryptococcal Meningitis. | Q52559853 | ||
| Deregulated tyrosine-phenylalanine metabolism in pulmonary tuberculosis patients. | Q53310316 | ||
| T-cell-based assays on cerebrospinal fluid and PBMCs for rapid diagnosis of TB meningitis in non-HIV patients. | Q53385812 | ||
| Evaluation of adapted whole-blood interferon-gamma release assays for the diagnosis of pleural tuberculosis. | Q53481127 | ||
| Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis. | Q53719641 | ||
| Streptococcus pneumoniae’s Virulence and Host Immunity: Aging, Diagnostics, and Prevention. | Q55514832 | ||
| The Brain-Gut-Microbiome Axis | Q57120648 | ||
| The gut-brain axis in health neuroscience: implications for functional gastrointestinal disorders and appetite regulation | Q57162390 | ||
| The Gut-Microglia Connection: Implications for Central Nervous System Diseases | Q57817925 | ||
| Global metabolic profiling procedures for urine using UPLC–MS | Q58045640 | ||
| Brain-Gut Axis: Clinical Implications | Q58548909 | ||
| Microglia Enhance Synapse Activity to Promote Local Network Synchronization | Q58555182 | ||
| Microbiome-microglia connections via the gut-brain axis | Q58559445 | ||
| The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue | Q58704148 | ||
| Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke | Q60045680 | ||
| Oxidative Stress, Cytokine/Chemokine and Disruption of Blood–Brain Barrier in Neonate Rats After Meningitis by Streptococcus agalactiae | Q60213090 | ||
| Brain-Gut-Microbiota Axis in Alzheimer's Disease | Q60923090 | ||
| Immunopathology of multiple sclerosis | Q63285399 | ||
| Metabolomics of Mycobacterium tuberculosis Reveals Compartmentalized Co-Catabolism of Carbon Substrates | Q63370394 | ||
| Use of Urine Volatile Organic Compounds To Discriminate Tuberculosis Patients from Healthy Subjects | Q64005193 | ||
| Immunity Against Bacterial Infection of the Central Nervous System: An Astrocyte Perspective | Q64056647 | ||
| Autism Spectrum Disorders and the Gut Microbiota | Q64091080 | ||
| Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease | Q64093651 | ||
| Application of Cerebrospinal Fluid Host Protein Biosignatures in the Diagnosis of Tuberculous Meningitis in Children from a High Burden Setting | Q64241066 | ||
| Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multipl | Q64450175 | ||
| N-aacetylanthranilic acid biosynthesis in Aerobacteraerogenes and Escherichia coli | Q69936778 | ||
| Assessment of the role of the glutathione and pentose phosphate pathways in the protection of primary cerebrocortical cultures from oxidative stress | Q71082209 | ||
| Susceptibility of brain and skin to bacterial challenge | Q72136771 | ||
| Overexpression of circulating vascular endothelial growth factor (VEGF) in leukocytoclastic vasculitis | Q73362266 | ||
| Oxidative stress in childhood meningitis: measurement of 8-hydroxy-2'-deoxyguanosine concentration in cerebrospinal fluid | Q73364144 | ||
| Diagnostic evaluation of urinary lipoarabinomannan at an Ethiopian tuberculosis centre | Q73855728 | ||
| Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation | Q73898865 | ||
| Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165 | Q73935037 | ||
| Evaluation of free radical status in CSF in childhood meningitis | Q74179131 | ||
| Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1 | Q77426354 | ||
| Analysis of the pathway structure of metabolic networks | Q78248329 | ||
| Expression of matrix metalloproteinases, sICAM-1 and IL-8 in CSF from children with meningitis | Q78652323 | ||
| Microbes' roadmap to neurons | Q37876692 | ||
| Understanding the role of gut microbiome-host metabolic signal disruption in health and disease | Q37891554 | ||
| Structure and function relationships in IgA. | Q37936765 | ||
| Signaling in innate immunity and inflammation | Q37980557 | ||
| The interplay between the intestinal microbiota and the brain | Q38045736 | ||
| Role of oxidative stress in infectious diseases. A review. | Q38090568 | ||
| Stratification and compartmentalisation of immunoglobulin responses to commensal intestinal microbes | Q38163162 | ||
| Pattern recognition receptors in innate immunity, host defense, and immunopathology | Q38167648 | ||
| Angiogenesis revisited - role and therapeutic potential of targeting endothelial metabolism | Q38245402 | ||
| Screening of latent tuberculosis infection by interferon-γ release assays in rheumatic patients: a systemic review and meta-analysis | Q38265740 | ||
| Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability | Q38510131 | ||
| Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies | Q38539643 | ||
| Innate and adaptive immune responses in the CNS. | Q38570574 | ||
| Physiological conditions can be reflected in human urine proteome and metabolome | Q38608509 | ||
| Body Fluid Interferon-γ Release Assay for Diagnosis of Extrapulmonary Tuberculosis in Adults: A Systematic Review and Meta-Analysis | Q38616798 | ||
| Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectives | Q38769147 | ||
| Diagnostic accuracy of interferon-gamma release assays for tuberculous meningitis: a meta-analysis | Q38771381 | ||
| Neuroinflammation: the devil is in the details | Q38779873 | ||
| Brain-gut-microbiota axis: challenges for translation in psychiatry. | Q38785581 | ||
| Inflammatory Response in the CNS: Friend or Foe? | Q38790379 | ||
| Myeloperoxidase: Bridging the gap in neurodegeneration | Q38876939 | ||
| Manipulating Angiogenesis by Targeting Endothelial Metabolism: Hitting the Engine Rather than the Drivers-A New Perspective? | Q38882106 | ||
| Lipoarabinomannan enzyme-linked immunosorbent assay for early diagnosis of childhood tuberculous meningitis. | Q38912039 | ||
| Detection of mycobacterial lipoarabinomannan with an antigen-capture ELISA in unprocessed urine of Tanzanian patients with suspected tuberculosis | Q38912905 | ||
| Signals from the gut microbiota to distant organs in physiology and disease | Q38973619 | ||
| Bacterial infections | Q39031612 | ||
| The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases | Q39052041 | ||
| Infectious immunity in the central nervous system and brain function | Q39090558 | ||
| Sharpening Host Defenses during Infection: Proteases Cut to the Chase | Q39127087 | ||
| The infectious etiology of Alzheimer's Disease | Q39178926 | ||
| Bacterial profile and clinical outcome of childhood meningitis in rural Yemen: a 2-year hospital-based study | Q39194534 | ||
| Acute bacterial meningitis in adults: a hospital based study in Yemen | Q39195965 | ||
| Cerebrospinal fluid cytokines in patients with tuberculous meningitis | Q39223365 | ||
| Acute bacterial meningitis in adults. A review of 493 episodes | Q39411298 | ||
| Temporal changes of oxidative stress markers in Escherichia coli K1-induced experimental meningitis in a neonatal rat model | Q40184474 | ||
| Oxidative stress and S-100B protein in children with bacterial meningitis | Q33509386 | ||
| Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis | Q33553788 | ||
| Cerebrospinal fluid concentrations of interleukin-1 beta, tumour necrosis factor-alpha, and interferon gamma in bacterial meningitis | Q33624341 | ||
| The role of microglia and macrophages in the pathophysiology of the CNS. | Q33643184 | ||
| Interleukin-1beta in immune cells of the abdominal vagus nerve: a link between the immune and nervous systems? | Q33844708 | ||
| Rapid diagnosis of Mycobacterium tuberculosis meningitis by enumeration of cerebrospinal fluid antigen-specific T-cells. | Q33854452 | ||
| Relationship between intracranial granulomas and cerebrospinal fluid levels of gamma interferon and interleukin-10 in patients with tuberculous meningitis | Q33859116 | ||
| Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance | Q33899037 | ||
| Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. | Q34003220 | ||
| Myeloperoxidase-generated oxidants and atherosclerosis | Q34006268 | ||
| Urinary p-cresol in autism spectrum disorder. | Q34033602 | ||
| Biomarkers of myeloperoxidase-derived hypochlorous acid | Q34054210 | ||
| The role of pro-inflammatory S100A9 in Alzheimer's disease amyloid-neuroinflammatory cascade | Q34104401 | ||
| Cerebrospinal T-cell responses aid in the diagnosis of tuberculous meningitis in a human immunodeficiency virus- and tuberculosis-endemic population | Q34118528 | ||
| Acute bacterial meningitis in adults. A 12-year review | Q34121962 | ||
| Role of Mycobacterium tuberculosis pknD in the pathogenesis of central nervous system tuberculosis | Q34127301 | ||
| The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice | Q34193512 | ||
| Further studies on anthranilate N-acetyltransferase and the metabolism of N-acetylanthranilic acid in Aerobacter aerogenes | Q34218054 | ||
| M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection | Q34287451 | ||
| Gut-brain axis: how the microbiome influences anxiety and depression | Q34326411 | ||
| Altered fecal microbiota composition in patients with major depressive disorder. | Q34472196 | ||
| Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. | Q34476924 | ||
| Gut microbiome and the risk factors in central nervous system autoimmunity. | Q34624054 | ||
| Myeloperoxidase-derived oxidants induce blood-brain barrier dysfunction in vitro and in vivo | Q34731236 | ||
| Altered colonic function and microbiota profile in a mouse model of chronic depression. | Q34775070 | ||
| Microglia as neuroprotective, immunocompetent cells of the CNS. | Q34963638 | ||
| Principles and clinical implications of the brain-gut-enteric microbiota axis | Q34978494 | ||
| The second brain and Parkinson's disease. | Q34999864 | ||
| Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury | Q35120141 | ||
| Correlation between the human fecal microbiota and depression. | Q35179996 | ||
| Vagal pathways for microbiome-brain-gut axis communication | Q35201577 | ||
| Mycobacterium tuberculosis metabolism | Q35245286 | ||
| Pneumolysin with low hemolytic activity confers an early growth advantage to Streptococcus pneumoniae in the blood. | Q35272956 | ||
| Induction of pulmonary indoleamine 2,3-dioxygenase by interferon | Q35300850 | ||
| Gut microbiota are related to Parkinson's disease and clinical phenotype | Q35492461 | ||
| Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis. | Q35543896 | ||
| Autism spectrum disorders and intestinal microbiota | Q35593028 | ||
| Brain-gut-microbe communication in health and disease | Q35597520 | ||
| Early Life Experience and Gut Microbiome: The Brain-Gut-Microbiota Signaling System | Q35737216 | ||
| A hypothetical astrocyte-microglia lactate shuttle derived from a (1)H NMR metabolomics analysis of cerebrospinal fluid from a cohort of South African children with tuberculous meningitis. | Q35763118 | ||
| Diagnostic Value of T-Cell Interferon-γ Release Assays on Cerebrospinal Fluid for Tuberculous Meningitis | Q35834564 | ||
| Effect of immunosuppressive therapy on interferon γ release assay for latent tuberculosis screening in patients with autoimmune diseases: a systematic review and meta-analysis. | Q35867272 | ||
| Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults | Q35868597 | ||
| A gut (microbiome) feeling about the brain | Q35892559 | ||
| Demyelinating diseases: myeloperoxidase as an imaging biomarker and therapeutic target. | Q35896745 | ||
| Microbes and the mind: emerging hallmarks of the gut microbiota-brain axis | Q35937089 | ||
| Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis. | Q35963484 | ||
| Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review. | Q35965052 | ||
| Microbiome: Bacterial broadband | Q36020831 | ||
| Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients. | Q36027979 | ||
| Oxidative stress and myeloperoxidase activity during bacterial meningitis: effects of febrile episodes and the BBB permeability | Q40377257 | ||
| Pathology and pathogenetic mechanisms in neurotuberculosis | Q40443742 | ||
| Aseptic meningitis in children: correlation between fever and interferon-gamma level | Q40745965 | ||
| Diagnosis of Tuberculous Meningitis Using a Combination of Peripheral Blood T-SPOT.TB and Cerebrospinal Fluid Interferon-γ Detection Methods | Q40844773 | ||
| VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain | Q40857831 | ||
| The molecular cell biology of interferon-gamma and its receptor | Q40898233 | ||
| Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus | Q40978202 | ||
| Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration | Q41097407 | ||
| Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. | Q41151821 | ||
| Regulation of and intervention into the oxidative pentose phosphate pathway and adenine nucleotide metabolism in the heart | Q41196211 | ||
| Biological properties of pneumolysin | Q41435662 | ||
| Microbiota-gut-brain axis and the central nervous system | Q41593417 | ||
| Host immune response to tuberculous meningitis | Q41707503 | ||
| Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37. | Q41825787 | ||
| VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells | Q42815794 | ||
| Biosynthesis of N-acetylanthranilic acid by aromatic auxotrophs of Aerobacter aerogenes and Escherichia coli | Q42926175 | ||
| A Word of Caution in Considering the Use of the Lipoarabinomannan Lateral Flow Assay on Cerebrospinal Fluid for Detection of Tuberculous Meningitis | Q43103600 | ||
| Rapid diagnosis of tuberculous meningitis by T cell-based assays on peripheral blood and cerebrospinal fluid mononuclear cells | Q43104716 | ||
| Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls | Q43119044 | ||
| VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly | Q43512732 | ||
| Oxidative stress in brain during experimental bacterial meningitis: differential effects of alpha-phenyl-tert-butyl nitrone and N-acetylcysteine treatment | Q43737726 | ||
| Oxidative stress in bacterial meningitis in humans | Q43863112 | ||
| Mycobacterium tuberculosis-induced cytokine and chemokine expression by human microglia and astrocytes: effects of dexamethasone | Q44436529 | ||
| Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis. | Q44646186 | ||
| Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. | Q44737250 | ||
| Vascular endothelial growth factor and blood-brain barrier disruption in tuberculous meningitis. | Q44973461 | ||
| Neuronal expression of myeloperoxidase is increased in Alzheimer's disease | Q44980217 | ||
| Vascular endothelial growth factor in bacterial meningitis: detection in cerebrospinal fluid and localization in postmortem brain. | Q45185342 | ||
| The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members. | Q46020123 | ||
| Oxidative stress in cerebrospinal fluid of patients with aseptic and bacterial meningitis | Q46127086 | ||
| Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents. | Q46322263 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | Mycobacterium tuberculosis | Q130971 |
| P304 | page(s) | 296 | |
| P577 | publication date | 2020-04-21 | |
| P1433 | published in | Frontiers in Neuroscience | Q2177807 |
| P1476 | title | Overview of Brain-to-Gut Axis Exposed to Chronic CNS Bacterial Infection(s) and a Predictive Urinary Metabolic Profile of a Brain Infected by Mycobacterium tuberculosis | |
| P478 | volume | 14 |
Search more.